Literature DB >> 26038237

Tentative identification of new metabolites of cnidilin by liquid chromatography-mass spectrometry.

Haoli Huo1, Peipei Jia1, Xiaoxu Zhang1, Zhiyong Zhang1, Haotian Yang1, Qiaoyue Zhang1, He Shi1, Lantong Zhang2.   

Abstract

Cnidilin is one of the major bioactive constituents of Radix Angelicae dahuricae. The present study was designed to characterize and interpret the structures of metabolites in rats after oral administration of cnidilin at a dose of 48mg/kg body weight. Metabolite identification was accomplished using a predictive multiple reaction monitoring-information-dependent acquisition-enhanced product ion (pMRM-IDA-EPI) scan and precursor ion scan-information-dependent acquisition-enhanced product ion (PREC-IDA-EPI) scan in positive ion mode. Comparing the changes in protonated molecular masses, MS/MS spectra and retention times with the parent drug, 18 metabolites were identified. The result shows that the metabolic pathways contain deisopentenyl, combination with glucose, hydroxylation, oxidation, demethylation and addition reaction. The study identified 18 metabolites, analyzed and summarized the fragmentation regularities of mass spectra of 8-methoxy-5-hydroxy psoralen. The study provides a new pathway to discovery new compounds, new fragmentation regularities and the mode of metabolites.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cnidilin; HPLC–ESI-MS; Identification; Metabolites

Mesh:

Substances:

Year:  2015        PMID: 26038237     DOI: 10.1016/j.jchromb.2015.05.002

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  An Integrated Strategy for Global Qualitative and Quantitative Profiling of Traditional Chinese Medicine Formulas: Baoyuan Decoction as a Case.

Authors:  Xiaoli Ma; Xiaoyu Guo; Yuelin Song; Lirui Qiao; Wenguang Wang; Mingbo Zhao; Pengfei Tu; Yong Jiang
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

Review 2.  Stepping forward in antibody-drug conjugate development.

Authors:  Yiming Jin; Megan A Schladetsch; Xueting Huang; Marcy J Balunas; Andrew J Wiemer
Journal:  Pharmacol Ther       Date:  2021-06-24       Impact factor: 12.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.